Non‐steroid agents for idiopathic pulmonary fibrosis
P Spagnolo, C Del Giovane, F Luppi… - Cochrane Database …, 1996 - cochranelibrary.com
Abstract Background Idiopathic Pulmonary Fibrosis (IPF) or Usual Interstitial Pneumonia
(UIP) is a form of chronic fibrosing interstitial pneumonia of unknown aetiology, with …
(UIP) is a form of chronic fibrosing interstitial pneumonia of unknown aetiology, with …
Immunomodulatory agents for idiopathic pulmonary fibrosis.
HR Davies, L Richeldi, EH Walters - The Cochrane database of …, 2003 - europepmc.org
Background Idiopathic Pulmonary Fibrosis (IPF) or Usual Interstitial Pneumonia (UIP) is a
form of chronic fibrosing interstitial pneumonia of unknown aetiology, with progressively …
form of chronic fibrosing interstitial pneumonia of unknown aetiology, with progressively …
Corticosteroids for idiopathic pulmonary fibrosis
L Richeldi, HRHR Davies, P Spagnolo… - Cochrane database …, 1996 - cochranelibrary.com
Background Idiopathic pulmonary fibrosis (IPF) is a disease with significant morbidity and
mortality. Patients short survival time, high mortality and generally rapid decline raise the …
mortality. Patients short survival time, high mortality and generally rapid decline raise the …
Current and future therapeutic approaches in idiopathic pulmonary fibrosis
D Bouros, KM Antoniou - European Respiratory Journal, 2005 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a lethal form of idiopathic diffuse lung disorders for
which no current treatment is effective. The aim of the present study was to systematically …
which no current treatment is effective. The aim of the present study was to systematically …
[HTML][HTML] Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis
F Luppi, S Cerri, B Beghè, LM Fabbri, L Richeldi - Respiratory medicine, 2004 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a progressive pulmonary disease leading to death
within a few years of diagnosis despite medical therapy. On the basis of methodologies of …
within a few years of diagnosis despite medical therapy. On the basis of methodologies of …
The big clinical trials in idiopathic pulmonary fibrosis
F Luppi, P Spagnolo, S Cerri… - Current opinion in …, 2012 - journals.lww.com
Despite multiple clinical trials, there is no strong, definitive evidence in favor of any agent to
treat IPF. On the other hand, the placebo arms of these large trials have provided us with …
treat IPF. On the other hand, the placebo arms of these large trials have provided us with …
Corticosteroids in idiopathic pulmonary fibrosis
JP Lynch III, E White, K Flaherty - Current opinion in pulmonary …, 2001 - journals.lww.com
Corticosteroids were the mainstay of therapy for idiopathic pulmonary fibrosis (IPF) for more
than four decades, but their efficacy is unproven and toxicities are substantial. The course of …
than four decades, but their efficacy is unproven and toxicities are substantial. The course of …
Treatment of idiopathic pulmonary fibrosis: a network meta-analysis
Background Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease associated with
high morbidity and mortality. Effective treatments for IPF are limited. Several recent studies …
high morbidity and mortality. Effective treatments for IPF are limited. Several recent studies …
German guideline for idiopathic pulmonary fibrosis–update on pharmacological therapies 2017
J Behr, A Günther, F Bonella, K Geißler… - …, 2018 - thieme-connect.com
Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease with a median survival
of 2–4 years after diagnosis. Since the publication of the German IPF guideline in 2013 new …
of 2–4 years after diagnosis. Since the publication of the German IPF guideline in 2013 new …
[HTML][HTML] Outcomes in idiopathic pulmonary fibrosis: a meta-analysis from placebo controlled trials
CP Atkins, YK Loke, AM Wilson - Respiratory Medicine, 2014 - Elsevier
Background Most data on outcomes in Idiopathic Pulmonary Fibrosis (IPF) pre-dates current
guidelines. Data on rates of infection is sparse; the effect of low-dose corticosteroids and …
guidelines. Data on rates of infection is sparse; the effect of low-dose corticosteroids and …